2022
DOI: 10.1093/ehjacc/zuac108
|View full text |Cite
|
Sign up to set email alerts
|

Acetazolamide for patients with acute decompensated heart failure with volume overload

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…However, these treatments are often insufficient in significantly reducing rehospitalization rates and mortality, even when patients adhere to established guidelines ( Lai et al, 2022 ). Moreover, traditional medication can lead to adverse effects, including hypotension, hypokalemia, and renal function impairment ( Hubers and Brown, 2016 ; Marciniak and Serebruany, 2019 ; Rossello et al, 2022 ). Consequently, there is a pressing need to explore new therapeutic agents to enhance survival rates and improve the quality of life for HF patients.…”
Section: Pharmacological Action Of Rg3 In Heart Diseasesmentioning
confidence: 99%
“…However, these treatments are often insufficient in significantly reducing rehospitalization rates and mortality, even when patients adhere to established guidelines ( Lai et al, 2022 ). Moreover, traditional medication can lead to adverse effects, including hypotension, hypokalemia, and renal function impairment ( Hubers and Brown, 2016 ; Marciniak and Serebruany, 2019 ; Rossello et al, 2022 ). Consequently, there is a pressing need to explore new therapeutic agents to enhance survival rates and improve the quality of life for HF patients.…”
Section: Pharmacological Action Of Rg3 In Heart Diseasesmentioning
confidence: 99%